Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy.
A study of the prevalence of hypertension in a group of renal transplant patients on alternate-day maintenance steroid therapy was conducted. Twenty-four percent of the transplant clinic population was hypertensive. The factors that were associated with a lower prevalence of hypertension were good graft function, bilateral nephrectomy of the patients' own diseased kidneys (although the majority of our patients without bilateral nephrectomy are normotensive), and use of a living related donor. We conclude that the prevalance of hypertension in transplant patients on alternate-day steroid therapy is low. In the presence of all these favorable factors, only 6% of allograft recipients were hypertensive.
D000293:Adolescent; D000328:Adult; D002102:Cadaver; D003404:Creatinine / Q000097:blood; D004334:Drug Administration Schedule; D005260:Female; D006084:Graft Rejection / Q000097:blood / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000097:blood*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D011183:Postoperative Complications / Q000097:blood*; D011241:Prednisone / Q000097:blood; D011507:Proteinuria / Q000097:blood; D014184:Transplantation, Homologous
D003404:Creatinine; D011241:Prednisone